Home


APB CHINA2 

 

 

Grand opening of Applikon Biotechnology China factory in Guangzhou.

Wednesday March 19th the Chinese factory of Applikon Biotechnology in Guangzhou has officially been opened. The presence of Chinese and Dutch goverment officials, highlighted the importance of this new milestone in the rapid development of our company. The factory is already operational since the end of 2013 and has assembled over 50 bioreactor systems. This extra capacity is needed to be able to cope with the increasing demand for Applikon bioreactors in China, the USA and in the rest of the world.
 
The opening ceremony was combined with a seminar titled:Innovations in bioreactor technology". International speakers presented new developments in bioreactor technology and showed the results of scientific cooperations between Applikon Biotechnology and several Universities.

 

 

 

 

 

 

Applikon Biotechnology  Seminar

 

“Bioreactor technology for CMO biopharma in a Life Sciences Supporting Environment”

 

On Monday March 17th 2014 Applikon Biotechnology organizes a life science seminar in Shanghai, China.

 

Focus of the seminar is on new developments in supporting structures for life science companies  with special attention for innovative bioreactor technology for contract manufacturing organizations in the bio pharmaceutical industry. The location of the seminar is the Kerry Hotel in Pudong, Shanghai. A selection of prominent speakers will shine their light on developments in infrastructure that will enable life science companies in general and more specific CMO’s  to be more successful in bringing new products to the market in the shortest possible time.

 

The seminar is Supported by: 

 

             Biotech Campus Delft, Netherlands

             DSM, China

             Innovation Quarter, Netherlands

             Leiden Bio Science Park, Netherlands

             National Antibody Center, China

             Ovizio, Belgium

             Province of Zuid-Holland, Netherlands

             Shanghai Pudong Bio Industry Association, China

             Shanghai Pudong Science & Technology Committee, China

             Wuxi Apptech Co. Ltd., China

             Zhangjiang Bio Pharmaceutical Co.Ltd., China 

 

 

Program:

14.00 - 14.10

Introduction ‘South Holland Province life sciences landscape- an overview of the key players’
by vice-governor Govert Veldhuijzen

 

 

14.10 - 14.20

Introduction ‘Shanghai life sciences landscape- an overview of the key players’
by Mrs. Kong Lingyi, section chief Shanghai Pudong Science & technology committee

 

 

14.20 - 14.30

An introduction to Applikon Biotechnology and its innovations in bioreactor technology,
by Arthur Oudshoorn, Managing Director Applikon Biotechnology

 

 

14.30 - 14.50

DSM innovation and bio mass,
by dr. Yin Qingyuan, R&D Center DSM Shanghai

 

 

14.50 - 15.10

Perfusion technology for low volume high & efficiency production
by Timo Keijzer, product manager Applikon Biotechnology

 

 

15.10 - 15.30

Leiden Bio Science Park: hot spot for business and training in biotechnology,
by Mrs. Nettie Buitelaar, CEO Leiden Bio Science Park

 

 

15.30 - 15.45

Sensor technology innovations
by Martijn Kreukniet, product manager Applikon Biotechnology

 

 

15.45 - 16.05

Coffee & tea break

 

 

16.05 - 16.25

Recent developments in biotechnology research in China
by dr. Ni Jian, GM of the National Antibody center

 

 

16.25 - 16.45

CMO / CRO benefit for China’s biopharma industry
by Weichang Zhou, Ph.D. VP, WuXi AppTec Co., Ltd

 

 

16.45 - 17.00

Automating process control by using innovative label-free 4-d quantative imaging,
by dr. Philip Mathuis, CEO Ovizio

 

 

17.00 - 17.15

Innovation Quarter & Biotech Campus Delft,

by Chris van Voorden, director Marketing, Innovation Quarter

 

 

17.15 - 17.20

Conclusions by Arthur Oudshoorn

 

For additional information on this seminar please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

 

 

 

 

 

 

King Willem-Alexander has opened our new headquarters

 

Opening klein 

On Wednesday December 4th the new headquarters of Applikon Biotechnology in Delft, the Netherlands has been officially opened by His Majesty King Willem-Alexander of the Netherlands. The grand opening was attended by (inter)national customers, business relations,(inter)national officials, scientific relations and the entire team of the Applikon Biotechnology in the Netherlands.

The new production facility has been operational for several months and the official opening was to officially mark this further step in the development and growth of Applikon Biotechnology. Company owners Arthur Oudshoorn, Jaap Oostra and Erik Kakes, and their dedicated team are proud and happy with these new premises which house the state-of-the-art warehouse and production facilities, R&D laboratory space and offices for approximately 100 employees.

In this new facility, Applikon Biotechnology  is now able to provide a complete range of bioreactor systems ranging from micro liter research volumes up to 15.000 liter production systems for pharmaceutical and biotechnological applications. 

 

 
News

newsflashIntroducing: micro-Matrix,

the next generation in microbioreactors

The unique micro-Matrix offers total control over 24 independent bioreactors in a simple microtiter plate footprint.Each of the 24 bioreactors on a plate offer independent controls like its larger stirred-tank relatives:

• pH (measurement and two-sided control)
• temperature (measurement and two-sided control, including plate-wide gradients)• dissolved oxygen control (measurement and two-sided control)
• individual liquid additions (including feeding profiles)
• up to 4 separate gas additions (individually controlled)

 

 MMAtrix 02 View06

Read more...
 

BioSenz Glucose Bio Analyzer

 

The Applikon BioSenz is a unique measuring device specifically developed for analysing glucose in bioreactors.

The heat-flux technology is a proprietary and patented technology for continuous measurement with high precision and repeatability. The technology that is used in intensive care units and other medical applications is brought to the biotech industry to finally allow accurate measurement of glucose in bioprocesses without interference from other medium compounds.

Read more...
 
<< Start < Prev 1 2 3 Next > End >>

Page 1 of 3
 
     Go to top   

logo2

 

 

 


 

 

 

 

 

© Copyright 2013 Applikon Biotechnology